Chargement en cours...
Volumetric tumor response and progression in EGFR-mutant NSCLC patients treated with erlotinib or gefitinib
OBJECTIVE: Investigate the association between 8-week tumor volume decrease and survival in an independent cohort of EGFR-mutant advanced non-small-cell lung cancer (NSCLC) patients treated with first-line erlotinib or gefitinib, and assess the rate of their volumetric tumor growth after the volume...
Enregistré dans:
| Publié dans: | Acad Radiol |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4744559/ https://ncbi.nlm.nih.gov/pubmed/26776293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.acra.2015.11.005 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|